↓ Skip to main content

Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss

Overview of attention for article published in BMC Infectious Diseases, October 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
48 Dimensions

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss
Published in
BMC Infectious Diseases, October 2014
DOI 10.1186/1471-2334-14-542
Pubmed ID
Authors

Chawangwa Modongo, Rafal S Sobota, Boikobo Kesenogile, Ronald Ncube, Giorgio Sirugo, Scott M Williams, Nicola M Zetola

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 21%
Researcher 13 12%
Student > Ph. D. Student 12 11%
Student > Bachelor 9 8%
Other 7 7%
Other 21 20%
Unknown 22 21%
Readers by discipline Count As %
Medicine and Dentistry 36 34%
Nursing and Health Professions 14 13%
Unspecified 5 5%
Immunology and Microbiology 4 4%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 15 14%
Unknown 29 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2024.
All research outputs
#7,845,794
of 25,556,408 outputs
Outputs from BMC Infectious Diseases
#2,634
of 8,653 outputs
Outputs of similar age
#78,750
of 267,864 outputs
Outputs of similar age from BMC Infectious Diseases
#37
of 164 outputs
Altmetric has tracked 25,556,408 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 8,653 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,864 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 164 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.